Opin vísindi

Fletta eftir höfundi "Sigurdsson, Stefan"

Fletta eftir höfundi "Sigurdsson, Stefan"

Röðun: Raða: Niðurstöður:

  • Olafsdottir, Elinborg J.; Borg, Ake; Jensen, Maj Britt; Gerdes, Anne Marie; Johansson, Anna L.V.; Barkardottir, Rosa B.; Johannsson, Oskar T.; Ejlertsen, Bent; Sønderstrup, Ida Marie Heeholm; Hovig, Eivind; Lænkholm, Anne Vibeke; Hansen, Thomas van Overeem; Olafsdottir, Gudridur H.; Rossing, Maria; Jonasson, Jon G.; Sigurdsson, Stefan; Loman, Niklas; Nilsson, Martin P.; Narod, Steven A.; Tryggvadottir, Laufey (2020-11-24)
    Background: The natural history of breast cancer among BRCA2 carriers has not been clearly established. In a previous study from Iceland, positive ER status was a negative prognostic factor. We sought to identify factors that predicted survival after ...
  • Frick, Elisabet; Gudjonsson, Thorkell; Eyfjörð, Jórunn Erla; Jonasson, Jon; Tryggvadóttir, Laufey; Stefansson, Olafur; Sigurdsson, Stefan (Impact Journals, LLC, 2019-07-23)
    Estrogen receptor-positive breast cancer is subdivided into subtypes LuminalA and LuminalB, based on different expression patterns. MicroRNA-190b has been reported to be up-regulated in estrogen receptor-positive breast cancers. In this study we aimed ...
  • Piqué, Laia; Martinez de Paz, Alexia; Piñeyro, David; Martínez-Cardús, Anna; Castro de Moura, Manuel; Llinàs-Arias, Pere; Setien, Fernando; Gomez-Miragaya, Jorge; Gonzalez-Suarez, Eva; Sigurdsson, Stefan; Jónasson, Jón G.; Villanueva, Alberto; Vidal, August; Davalos, Veronica; Esteller, Manel (Springer Science and Business Media LLC, 2019-08-13)
    Human tumors show altered patterns of protein isoforms that can be related to the dysregulation of messenger RNA alternative splicing also observed in transformed cells. Although somatic mutations in core spliceosome components and their associated ...
  • Vidarsdottir, Linda; Olafsdottir, Elinborg J.; Barkardóttir, Rósa Björk; Bjarnadóttir, Ólöf Kristjana; Jónasson, Jón Gunnlaugur; Sigurdsson, Stefan; Tryggvadottir, Laufey (2023-11-30)
    Estrogen receptor-positive (ER+) breast cancer generally confers a more favorable prognosis than ER-negative cancer, however, a different picture is emerging for BRCA2 mutation carriers and young patients. We used nationwide data from population-based ...